Sonnet BioTherapeutics I...

NASDAQ: SONN · Real-Time Price · USD
3.43
0.21 (6.52%)
At close: Aug 21, 2025, 12:01 PM

Sonnet BioTherapeutics Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Net Income
-7.44M -18.83M -29.72M -24.98M
Depreciation & Amortization
83.11K 75.75K 93.26K 95.16K
Stock-Based Compensation
231.19K 248.63K 876.37K 1.38M
Other Working Capital
-1.94M -415.04K -877.58K -637.73K
Other Non-Cash Items
413.95K 282K 971.48K 623.00
Deferred Income Tax
n/a n/a n/a -125.5K
Change in Working Capital
-1.9M -3.12M 93.46K 1.09M
Operating Cash Flow
-8.61M -21.34M -27.69M -22.55M
Capital Expenditures
3.00 -443.25K -896.48K -3.62K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-12K -443.25K -896.48K -3.62K
Debt Repayment
n/a -748 n/a -20.44K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
2.6M 849.00 n/a n/a
Financial Cash Flow
6.49M 21.01M 4.01M 42.83M
Net Cash Flow
-2.12M -778.62K -24.57M 20.27M
Free Cash Flow
-8.61M -21.79M -28.58M -22.56M